Breast cancer survivors aren't getting regular follow-up mammograms, according to a study published in the May issue of the Journal of the National Comprehensive Cancer Network.
National Comprehensive Cancer Network (NCCN) guidelines recommend annual mammograms for the early detection of recurrence in women who have had breast cancer. But a team led by Dr. Kathryn Ruddy from the Mayo Clinic in Rochester, MN, found that mammography rates declined over time as breast cancer survivors got further out from their diagnosis.
The researchers also found that black breast cancer survivors were less likely than their white counterparts to undergo regular mammography based on the recommended schedule.
Ruddy and colleagues followed 27,212 patients for a median of 2.9 years after breast cancer surgery. Of these, 4,790 patients remained in the study cohort for at least 65 months. One year out from surgery, 13% of the survivors had not undergone any breast imaging; this number rose to 19% by five years after surgery. Only 50% of the patients who were followed for at least five years had at least one mammogram each of those five years (J Natl Compr Canc Netw, May 2018, Vol. 16:5, pp. 526-534).
"Clinicians need to make sure that their patients are fully aware of the role annual mammograms play in screening for new breast cancers as well as for local recurrences," Ruddy said in a statement released by the NCCN. "Creating and implementing survivorship care plans with clear follow-up instructions may help ensure that more survivors adhere to recommended screening schedules."













![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)





